IBOV 172,457.76 ▲ 0.66% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL5.67▼ 0.02% USD/MXN18.58▲ 0.40% USD/CLP994.16▼ 0.13% USD/COP 3,303 — 0.00% USD/PEN3.41▲ 0.11% USD/ARS1,544▼ 0.02% USD/UYU 40.59 — 0.00% USD/PYG 6,196 — 0.00% USD/BOB 11.59 — 0.00% USD/DOP 60.59 — 0.00% USD/CRC 442.74 — 0.00% USD/GTQ 7.64 — 0.00% USD/HNL 26.91 — 0.00% USD/NIO 36.62 — 0.00% USD/VES911.74▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.69— 0.00% USD/TTD6.75— 0.00% EUR/BRL6.25▼ 0.04% BRENT 96.33 ▲ 0.51% WTI 89.23 ▲ 0.76% IRON ORE 161.91 — — COPPER 6.03 ▼ 0.76% GOLD 3,862 ▼ 0.63% SILVER 47.33 ▼ 3.47% SOY 1,227 ▼ 1.33% CORN 444.50 ▼ 0.22% WHEAT 589.25 ▼ 0.67% COFFEE 279.25 ▼ 0.34% SUGAR 18.40 ▲ 0.99% ORANGE JUICE 136.85 ▼ 2.91% COTTON 78.68 ▲ 0.01% COCOA 5,123 ▲ 1.13% BEEF 224.80 ▲ 2.70% CATTLE 335.35 ▼ 0.10% LITHIUM 58.76 ▼ 1.13% PETR4 45.30 — 0.00% VALE3 63.50 — 0.00% ITUB4 42.27 — 0.00% BBDC4 14.52 — 0.00% ABEV3 15.79 — 0.00% BBAS3 15.10 — 0.00% B3SA3 14.89 ▲ 0.88% WEGE3 51.31 ▼ 0.66% PRIO3 63.30 — 0.00% SUZB3 54.77 — 0.00% RENT3 30.07 — 0.00% AZZA3 15.91 — 0.00% CSAN3 3.10 ▲ 8.77% RAIZ4 20.00 — 0.00% PCAR3 2.56 ▲ 7.11% GMAT3 4.25 ▲ 10.68% PSSA3 46.41 ▲ 1.02% CVCB3 0.83 ▼ 1.19% POSI3 3.15 ▼ 6.53% SLCE3 18.28 ▼ 0.44% NATU3 5.13 ▼ 3.75% BRKM5 3.02 — 0.00% RANI3 8.18 — 0.00% CSNA3 3.72 — 0.00% IBOV 172,457.76 ▲ 0.66% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL 5.67 ▼ 0.02% USD/MXN 18.59 ▲ 0.45% USD/CLP 994.16 ▼ 0.13% USD/COP 3,303 — 0.00% USD/PEN 3.41 ▲ 0.15% USD/ARS 1,544 ▼ 0.02% USD/UYU 40.59 — 0.00% USD/PYG 6,196 — 0.00% USD/BOB 11.59 — 0.00% USD/DOP 60.59 — 0.00% USD/CRC 442.74 — 0.00% USD/GTQ 7.64 — 0.00% USD/HNL 26.91 — 0.00% USD/NIO 36.62 — 0.00% USD/VES 911.74 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.69 ▲ 2.75% USD/TTD 6.75 ▲ 2.58% EUR/BRL 6.25 ▼ 0.04% BRENT 96.33 ▲ 0.51% WTI 89.23 ▲ 0.76% IRON ORE 161.91 — — COPPER 6.03 ▼ 0.76% GOLD 3,862 ▼ 0.63% SILVER 47.33 ▼ 3.47% SOY 1,227 ▼ 1.33% CORN 444.50 ▼ 0.22% WHEAT 589.25 ▼ 0.67% COFFEE 279.25 ▼ 0.34% SUGAR 18.40 ▲ 0.99% ORANGE JUICE 136.85 ▼ 2.91% COTTON 78.68 ▲ 0.01% COCOA 5,123 ▲ 1.13% BEEF 224.80 ▲ 2.70% CATTLE 335.35 ▼ 0.10% LITHIUM 58.76 ▼ 1.13% PETR4 45.30 — 0.00% VALE3 63.50 — 0.00% ITUB4 42.27 — 0.00% BBDC4 14.52 — 0.00% ABEV3 15.79 — 0.00% BBAS3 15.10 — 0.00% B3SA3 14.89 ▲ 0.88% WEGE3 51.31 ▼ 0.66% PRIO3 63.30 — 0.00% SUZB3 54.77 — 0.00% RENT3 30.07 — 0.00% AZZA3 15.91 — 0.00% CSAN3 3.10 ▲ 8.77% RAIZ4 20.00 — 0.00% PCAR3 2.56 ▲ 7.11% GMAT3 4.25 ▲ 10.68% PSSA3 46.41 ▲ 1.02% CVCB3 0.83 ▼ 1.19% POSI3 3.15 ▼ 6.53% SLCE3 18.28 ▼ 0.44% NATU3 5.13 ▼ 3.75% BRKM5 3.02 — 0.00% RANI3 8.18 — 0.00% CSNA3 3.72 — 0.00%
since 2009
Monday, November 16, 2026

Covid-19 Brazil

AstraZeneca, Pfizer vaccines effective against Delta Covid-19 variants – study

By · · 2 min read

RIO DE JANEIRO, BRAZIL – Covid-19 vaccines made by AstraZeneca and the Pfizer-BioNTech alliance remain broadly effective against Delta and Kappa variants of the Covid-19-causing virus, which were first identified in India, according to a scientific study, underpinning a continued push to deliver the shots.

Vaccine

RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

The study by Oxford University researchers, published in the journal Cell, investigated the ability of antibodies in the blood of people, who were vaccinated with the two-shot regimens, to neutralize the highly contagious Delta and Kappa variants, a statement said.

“There is no evidence of widespread escape suggesting that the current generation of vaccines will provide protection against the B.1.617 lineage,” the paper said, referring to the Delta and Kappa variants by a commonly used code.

However, the concentration of neutralizing antibodies in the blood was somewhat reduced, which may lead to some breakthrough infections, they cautioned.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Exxon gets Guyana approval for a gas project”

Over 90% protection against hospitalization from Delta variant

Last week, an analysis by the Public Health England (PHE) showed that vaccines made by Pfizer Inc and AstraZeneca offer high protection of more than 90% against hospitalization from the Delta variant.

“We are encouraged to see the non-clinical results published from Oxford and these data, alongside the recent early real-world analysis from Public Health England, provide us with a positive indication that our vaccine can have a significant impact against the Delta variant,” AstraZeneca executive Mene Pangalos said in a separate statement.

The Delta variant is becoming the globally dominant version of the disease, the World Health Organization’s chief scientist said on Friday.

The Oxford researchers also analyzed reinfection patterns in people who had previously had Covid-19. The risk of reinfection with the Delta variant appeared particularly high in individuals previously infected by the Beta and Gamma lineages that emerged in South Africa and Brazil, respectively.

By contrast, previous infection with the Alpha, or B117, variant first detected in Britain, conferred “reasonable” cross-protection against all variants of concern, lending itself as a template that next-generation vaccines could be molded on.

“B117 might be a candidate for new variant vaccines to provide the broadest protection,” the researchers said.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.